BACKGROUND: Release of neutrophil extracellular traps (NETs) has been identified as an important aspect of innate immunity. We examined whether sepsis had any influence on ex vivo generation of NETs by neutrophils. MATERIALS AND METHODS: We isolated neutrophils from consecutive patients with sepsis (n = 17) and without sepsis (n = 18) admitted to the intensive care unit. Neutrophils were activated by incubation with phorbol-12-myristate-13-acetate (PMA) to induce release of NETs, and NET formation was assessed by measuring the extracellular DNA level. Immunolabeling and fluorescence imaging were also performed. Extracellular killing of bacteria by NETs was studied by co-culture of Escherichia coli and neutrophils in the presence of a phagocytosis inhibitor. To assess in vivo NET formation, plasma levels of cell-free DNA and histones were measured. RESULTS: After stimulation with PMA, neutrophils isolated from septic patients released 4.08 ± 1.02% of their total DNA, whereas neutrophils from nonseptic patients released 29.06 ± 2.94% (P = <0.0001). Immunofluorescent staining of released DNA, elastase, and myeloperoxidase also revealed similar results. Neutrophils from nonseptic patients showed effective extracellular killing of E coli through NETs, whereas neutrophils from septic patients did not (P < 0.001). Plasma levels of cell-free DNA and histones were higher in septic patients than nonseptic patients (P < 0.001). CONCLUSIONS: The ex vivo generation of NETs is downregulated in neutrophils isolated from patients with sepsis. However, it is unclear whether in vivo NET formation is also impaired during sepsis, so further investigation is necessary.
BACKGROUND: Release of neutrophil extracellular traps (NETs) has been identified as an important aspect of innate immunity. We examined whether sepsis had any influence on ex vivo generation of NETs by neutrophils. MATERIALS AND METHODS: We isolated neutrophils from consecutive patients with sepsis (n = 17) and without sepsis (n = 18) admitted to the intensive care unit. Neutrophils were activated by incubation with phorbol-12-myristate-13-acetate (PMA) to induce release of NETs, and NET formation was assessed by measuring the extracellular DNA level. Immunolabeling and fluorescence imaging were also performed. Extracellular killing of bacteria by NETs was studied by co-culture of Escherichia coli and neutrophils in the presence of a phagocytosis inhibitor. To assess in vivo NET formation, plasma levels of cell-free DNA and histones were measured. RESULTS: After stimulation with PMA, neutrophils isolated from septic patients released 4.08 ± 1.02% of their total DNA, whereas neutrophils from nonseptic patients released 29.06 ± 2.94% (P = <0.0001). Immunofluorescent staining of released DNA, elastase, and myeloperoxidase also revealed similar results. Neutrophils from nonseptic patients showed effective extracellular killing of E coli through NETs, whereas neutrophils from septic patients did not (P < 0.001). Plasma levels of cell-free DNA and histones were higher in septic patients than nonseptic patients (P < 0.001). CONCLUSIONS: The ex vivo generation of NETs is downregulated in neutrophils isolated from patients with sepsis. However, it is unclear whether in vivo NET formation is also impaired during sepsis, so further investigation is necessary.
Authors: Fatemeh Fattahi; Jamison J Grailer; Lawrence Jajou; Firas S Zetoune; Anuska V Andjelkovic; Peter A Ward Journal: Immunol Res Date: 2015-03 Impact factor: 2.829
Authors: Richard S Hotchkiss; Lyle L Moldawer; Steven M Opal; Konrad Reinhart; Isaiah R Turnbull; Jean-Louis Vincent Journal: Nat Rev Dis Primers Date: 2016-06-30 Impact factor: 52.329
Authors: Paula Giselle Czaikoski; José Maurício Segundo Correia Mota; Daniele Carvalho Nascimento; Fabiane Sônego; Fernanda Vargas e Silva Castanheira; Paulo Henrique Melo; Gabriela Trentin Scortegagna; Rangel Leal Silva; Romualdo Barroso-Sousa; Fabrício Oliveira Souto; Antonio Pazin-Filho; Florencio Figueiredo; José Carlos Alves-Filho; Fernando Queiróz Cunha Journal: PLoS One Date: 2016-02-05 Impact factor: 3.240
Authors: Ana B Arroyo; María P Fernández-Pérez; Alberto Del Monte; Sonia Águila; Raúl Méndez; Rebecca Hernández-Antolín; Nuria García-Barber; Ascensión M de Los Reyes-García; Paula González-Jiménez; María I Arcas; Vicente Vicente; Rosario Menéndez; Vicente Andrés; Rocío González-Conejero; Constantino Martínez Journal: Haematologica Date: 2021-06-01 Impact factor: 9.941
Authors: B A Boone; L Orlichenko; N E Schapiro; P Loughran; G C Gianfrate; J T Ellis; A D Singhi; R Kang; D Tang; M T Lotze; H J Zeh Journal: Cancer Gene Ther Date: 2015-04-24 Impact factor: 5.987
Authors: Philip J Vernon; Leasha J Schaub; Jurandir J Dallelucca; Anthony E Pusateri; Forest R Sheppard Journal: PLoS One Date: 2015-12-30 Impact factor: 3.240
Authors: R Ma; T Li; M Cao; Y Si; X Wu; L Zhao; Z Yao; Y Zhang; S Fang; R Deng; V A Novakovic; Y Bi; J Kou; B Yu; S Yang; J Wang; J Zhou; J Shi Journal: Cell Death Dis Date: 2016-06-30 Impact factor: 8.469